期刊文献+

影响老年充血性心力衰竭患者血清CA125的相关因素分析 被引量:12

Association of serum CA125 tumoral marker levels with heart function in the elderly with congestive heart failure
原文传递
导出
摘要 目的探讨老年冠心病慢性充血性心力衰竭(CHF)患者血清CA125水平与心功能等相关因素之间的关系。方法测定178例老年冠心病CHF患者血清肿瘤标志物CA125、癌胚抗原(CEA)、甲胎蛋白(AFP)、CA199、CA15—3、CA724以及肝肾功能和N末端脑钠肽(NT-proBNP);超声心动图测定二尖瓣舒张早期E峰最大流速(Ve)、舒张晚期A峰最大流速(Va)、Ve/Va、左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)及左心室射血分数(LVEF)、左心室射血时间。所有患者根据NYHA分为Ⅰ+Ⅱ、Ⅲ、Ⅳ级3组;统计其胸腔积液、外周水肿、心房颤动的发生率。结果(1)178例患者中血清CA125≤35U/m191例,CA125中位数9.9(3.4~33.7)U/ml;〉35U/m187例,中位数64.4(20.2—462.1)U/ml。CA125〉35U/ml组NYHA心功能Ⅲ+Ⅳ级82例,Ⅰ+Ⅱ级5例;≤35U/ml组Ⅲ+Ⅳ级7例,Ⅰ+Ⅱ级84例,组间心功能差异有统计学意义(X^2=133.3,P〈0.001)。CA125增高组胸腔积液、心房颤动、外周水肿的发生率高于CA125≤35U/ml组[32.2%(28/87)、5.5%(5/91),51.7%(45/87)、9.9%(9/91),78.2%(68/87)、19.8%(18/91),P均〈0.01],NT—proBNP、LVESD、LVEF、左心室射血时间比较差异均有统计学意义[2524.0(104.0~19308.0)、356.0(32.0—5201.1)ng/L,35(27—55)、32(26—53)mm,49%(23%-66%)、59%(42%~69%),268(210~312)、290(260~340)ms,P均〈0.05]。(2)直线回归显示:血清CA125与血浆NT—proBNP、尿素氮呈正相关(r=0.3326、P=0.002,r=0.3430、P=0.002),与LVEF、左心室射血时间呈负相关(r=-0.3016、P=0.006,r=-0.3336、P=0.004)。结论老年冠心病CHF患者血清CA125随着心功能分级恶化而升高,并且与血浆NT-proBNP水平、LVEF、左心室射血时间以及有无胸腔积液、心房颤动、外周水肿等因素有关。 Objective To assess the association between serum levels of carbohydrate antigen 125 (CA125) and the heart function in the elderly with congestive heart failure (CHF). Methods CA125, carcinoembryonic antigen ( CEA), alpha-fetoprotein ( AFP), CA199, CA15-3, CA724, liver and kidney function and NT-proBNP were measured in 178 patients with heart failure. Ve, Va, Ve/Va, left ventricular end-diastolic diamete ( LVEDD), left ventricular end-systolic diamete ( LVESD ), left ventricular ejection fraction (LVEF) and time were measured using echocardiograph. All patients were classified as Ⅰ + Ⅱ. Ⅲ and Ⅳ level according to the criteria of New York Heart Assocation ( NYHA), and the incidence of pleural effusion, peripheral edema, atrial fibrillation were observed. Results Among the 178 patients,serum CA125 were ≤35 U/ml in 91 patients with median of 9. 9 (3.4 - 33.7) U/ml, 〉 35 U/ml in 87 patients with median of 64.4 ( 20. 2 - 462. 1 ) U/ml. Among those patients with CA125 〉 35 U/ml ,heart function was classified as level Ⅲ + Ⅳ in 82 patients,and level Ⅰ + Ⅱ in 5 patients. Among the patients with CA125 ≤35 U/ml, heart function was classified as level Ⅲ + Ⅳin 7 patients, and level Ⅰ + Ⅱ in 84 patients. Heart function was significantly different between the two CA125 groups( X^2 = 133.3 ,P 〈 0. 001 ). The incidence of pleural effusion, atrial fibrillation, peripheral edema in the higher CA125 group were 32. 2% ,51.7% and 78.2% , respectively, which were significantly higher than those in the normal CA125 group ( 5.5% ,9.9% and 19.8%, repactively) ( P 〈 0. 01 ). NT-proBNP, LVESD, LVEF and time in the higher CA125 group were 2524. 0( 104. 0 - 19 308.0) ng/L,35 ( 27 - 55 ) mm ,49% (23% -66% ) and 268(210- 312)ms,which were significantly differenct from those in the normal CA125 group [ 356. 0 ( 32. 0 - 5201.0) ng/L, 32 ( 26 - 53 ) mm, 59% ( 42% - 69% ) and 290 ( 260 - 340 ) ms, respectively ] (Ps 〈0. 05). The linear regression showed that serum CA125 was positively correlated with NT-ProBNP and urea nitrogen ( BUN ) ( r = 0. 3326 and 0. 3430, Ps = 0. 002 ) , as well as negtively correlated with LVEF and time (r = -0. 3016,P =0. 006;r = -0. 336,P =0. 004). Conclusion Serum CA125 in the elderly with congestive heart failure increased with the worsing of heart function, and correlated with the level of NT-proBNP, LVEF and time, as well as pleural effusion, atrial fibrillation, peripheral edema.
出处 《中国综合临床》 2011年第3期252-255,共4页 Clinical Medicine of China
关键词 充血性心力衰竭 CA125 N末端脑钠肽 Congestive heart failure Carbohydrate antigen-125 N T-proBNP
  • 相关文献

参考文献10

  • 1Nǎgele H, Bahlo M, Klapdor R, et al. CA 125 and its relation to cardiac function [ J ]. Am Heart J, 1999,137 (6) : 1044-1049.
  • 2Kouris NT,Zacharos ID, Kontogianni DD, et al. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters[J]. Eur J Heart Fail,2005,7:199-203.
  • 3Duman D, Palit F, Simsek E, et al. Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume [ J ]. Eur J Heart Fail ,2008,10 (6) : 556-559.
  • 4Antonini-Canterin F,Popescu BA, Popescu AC, et al. Heart failure in patients with aortic stenosis:clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement [ J ]. Int J Cardio1,2008,128 ( 3 ) :406-412.
  • 5De Gennaro L, Brunetti ND, Bungaro R, et al. Carbohydrate antigen-125 : additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome [J]. Coron Artery Dis,2009,20 (4) :274-280.
  • 6王一波,金美玲,沈卫峰.血清CA125水平与充血性心力衰竭关系初探[J].临床内科杂志,2006,23(2):99-101. 被引量:23
  • 7孙水根,黄继华.血清CA125浓度改变对慢性心力衰竭患者临床诊治的价值[J].中华急诊医学杂志,2007,16(4):424-426. 被引量:27
  • 8陆弋,陈样新,方崇峰,江建军,唐礼江.血清糖类抗原125及血浆尿钠肽水平与充血性心力衰竭的关系[J].临床心血管病杂志,2007,23(8):582-584. 被引量:12
  • 9Duman C,Erean E,Tengiz l,et al. Elevated serum CA 125 levels in mitral stenotie patients with heart failure [ J ]. Cardiology ,2003,100 ( 1 ) :7-10.
  • 10Kosar F, Aksoy Y, Ozguntekin G, et al. Relationship between cytokines and tumour markers in patients with chronic heart failure [ J ]. Eur J Heart Fail,2006,8 ( 3 ) :270-274.

二级参考文献23

  • 1胡春松,魏云峰,朱文玲,徐进,YoonYS,罗伟,LosordoDW.心力衰竭患者血清CA125、CA19-9水平变化及意义[J].中国分子心脏病学杂志,2005,5(1):415-417. 被引量:14
  • 2Keulenaer G, Brutsaert D. Pathogenesis of heart failure changing conceptual paradigms. Acta Cardiol,1998,53:131-141.
  • 3The Criteria Committee of New York Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with disease of the heart. Circulation, 1994,90:644-645.
  • 4Nagele H, Marlies Bahol, Rainer Klapdor, et al. CA125 and its relation to cardiac function. Am Heart J, 1999,137 : 1044-1049.
  • 5Deleeuw PW,kroon AA. Hypertersion and the development of heart failure. Cardiovasc Pharmacol, 1998,32:9-15.
  • 6The Criteria Committee of New York Heart Association 1994 revisions to classlfication of functional capacity and objective assessment of patients with disease of the heart circulation [R], 1994, 90: 644-645.
  • 7Nagele H, Bahlo M, Klapdor R, et al. CA125 and its relation to cardiac function [J]. Am Heart J, 1999, 137 (6) : 1044-1049.
  • 8Kubonishi I , Bandobashi K, MUrata N , et al . High serum levels CA125 and interleukin-6 in patient with Ki-1 lymphoma [J]. Br J Haematol, 1997, 98 (2) : 450-452.
  • 9Deleuw PW, Kroon AA. Hypertension and the development of heart failure [J]. Cardiovase Phamacol, 1998, 32 (1): 9-15.
  • 10Turk HM , Pekdemir H , BuyuberberS , et al . Serum CA125 level sin patient s with chronic heart , failure and accompanyjng pleural fluid[J]. TumorBiol , 2003 , 24 (4) : 172-175.

共引文献48

同被引文献120

引证文献12

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部